PRA opens offices in Israel and Ukraine

By Alexandria Pesic

- Last updated on GMT

Related tags Middle east

Global clinical research organisation (CRO), PRA International, has opened two new offices in Israel and the Ukraine.

The North Carolina, US-based company said the offices, in Tel Aviv and Kiev, demonstrate its commitment to meet an “increased demand for services in the Middle East and Europe.”

Susan Stansfield, executive VP of product registration for Europe, Asia Pacific and Africa, told Outsourcing-Pharma the expansion reflects the “rapid and significant [market] growth in these countries over the past three ​years,” as well as the desire to provide customers with a tangible point of contact.

Continued delivery of high quality services to our customers and employees is best provided through having our staff benefit from physical offices versus home-working,”​ she said.

These offices offer a physical location for our teams to work from and provide face-to-face contact and interaction, plus logistics support.”

PRA now has 17 full-time employees in Israel after initially establishing its presence in the region in 2007. The Ukraine office, located in the business district of Podil, employs another 15 staff, including 10 clinical research associates.

High quality data

With a population of 50m, Ukraine has emerged as an attractive location for global studies. Stansfield believes that both Israel and Ukraine provide PRA with “all of the key ingredients” ​with which to conduct meaningful research.

For global clinical trials to be completed within reasonable timelines to preserve patent life, access to high quality data from suitable patient populations is critical,” ​she said.

Each of these countries provide regulatory framework, healthcare system, enthusiastic and well educated and trained investigator staff, and enthusiastic and well trained monitoring and support staff.

In addition, both provide a safe environment for both local and visiting personnel,” ​she added.

Global Presence

The new facilities serve to further strengthen PRA global presence, which currently extends to more than 80 countries

Commenting on the openings, Ludger Langer, PRA's vice president of clinical operations in Europe, Asia-Pacific and Africa, said: “We are please to be able to provide an increased level of staffing through new offices in these two countries. These facilities bolster our offerings by providing centralised support for local teams to serve our clients in these regions.”

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

Related suppliers

Follow us


View more